Panhypopituitarism - X-linked
|
0.510 |
GeneticVariation
|
disease |
BEFREE |
Duplications and deletions of Xq26-27 including SOX3 (Xq27.1) have been associated with X-linked mental retardation and isolated growth hormone deficiency (OMIM 300123) or X-linked panhypopituitarism (OMIM 312000).
|
29175558 |
2018 |
Isolated somatotropin deficiency
|
0.170 |
GeneticVariation
|
disease |
BEFREE |
Duplications and deletions of Xq26-27 including SOX3 (Xq27.1) have been associated with X-linked mental retardation and isolated growth hormone deficiency (OMIM 300123) or X-linked panhypopituitarism (OMIM 312000).
|
29175558 |
2018 |
Pituitary dwarfism
|
0.150 |
GeneticVariation
|
disease |
BEFREE |
Duplications and deletions of Xq26-27 including SOX3 (Xq27.1) have been associated with X-linked mental retardation and isolated growth hormone deficiency (OMIM 300123) or X-linked panhypopituitarism (OMIM 312000).
|
29175558 |
2018 |
Hypopituitarism
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
This is the first study to report that the rare SOX3 missense variant associated with hypopituitarism possibly due to increased activation of SOX3 target genes and disregulation of β-catenin target genes.
|
30125608 |
2018 |
Pseudohypoparathyroidism, Type Ia
|
0.070 |
GeneticVariation
|
disease |
BEFREE |
Pseudohypoparathyroidism type 1A (PHP1A), pseudoPHP (PPHP), and PHP type 1B (PHP1B) are caused by maternal and paternal GNAS mutations and abnormal methylation at maternal GNAS promoter(s), respectively.
|
29693731 |
2018 |
Mental Retardation, X-Linked
|
0.040 |
Biomarker
|
disease |
BEFREE |
Duplications and deletions of Xq26-27 including SOX3 (Xq27.1) have been associated with X-linked mental retardation and isolated growth hormone deficiency (OMIM 300123) or X-linked panhypopituitarism (OMIM 312000).
|
29175558 |
2018 |
Hypoparathyroidism
|
0.030 |
Biomarker
|
disease |
BEFREE |
BMD and related markers were compared between PHP and NS-HP patients.
|
29240265 |
2018 |
Carcinogenesis
|
0.030 |
Biomarker
|
phenotype |
BEFREE |
Sex determining region Y-box protein 3 (SOX3) is involved in embryonic development and tumorigenesis.
|
29484385 |
2018 |
Tumor Cell Invasion
|
0.030 |
AlteredExpression
|
phenotype |
BEFREE |
We also found that the downregulation of SOX3 decreased the expression of Snail, Twist and matrix metalloproteinase-9 (MMP-9), and increased E-cadherin expression, resulting in the inhibition of cell migration and invasion.
|
29484385 |
2018 |
Osteosarcoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
Taken together, our data indicate that SOX3 may serve as an oncogene in osteosarcoma, and SOX3 downregulation may prove to be a novel approach for the inhibition of osteosarcoma progression.
|
29484385 |
2018 |
Osteosarcoma of bone
|
0.020 |
Biomarker
|
disease |
BEFREE |
Taken together, our data indicate that SOX3 may serve as an oncogene in osteosarcoma, and SOX3 downregulation may prove to be a novel approach for the inhibition of osteosarcoma progression.
|
29484385 |
2018 |
Childhood Osteosarcoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
Taken together, our data indicate that SOX3 may serve as an oncogene in osteosarcoma, and SOX3 downregulation may prove to be a novel approach for the inhibition of osteosarcoma progression.
|
29484385 |
2018 |
Alzheimer's Disease
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
The aim of the present study was to evaluate the expression patterns of selected SOXB proteins in the SGZ, of 8-week-old male and female 5xFAD mice, which represent a transgenic model of AD with a severe and very early development of amyloid pathology.
|
30103323 |
2018 |
Failure to Thrive
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Increased transactivation and impaired repression of β-catenin-mediated transcription associated with a novel SOX3 missense mutation in an X-linked hypopituitarism pedigree with modest growth failure.
|
30125608 |
2018 |
Growth failure
|
0.010 |
GeneticVariation
|
phenotype |
BEFREE |
Increased transactivation and impaired repression of β-catenin-mediated transcription associated with a novel SOX3 missense mutation in an X-linked hypopituitarism pedigree with modest growth failure.
|
30125608 |
2018 |
metastatic intraocular melanoma
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
M-PHP results in durable intrahepatic disease control and can form the basis for an integrated multimodality treatment approach in appropriately selected UM patients.
|
29284076 |
2018 |
Tumor Cell Invasion
|
0.030 |
AlteredExpression
|
phenotype |
BEFREE |
Silencing of Sox3 in endometrial cancer stem cell upregulated the epithelial marker E-cadherin, downregulated the mesenchymal marker vimentin, and significantly reduced cell invasion in vitro; overexpression of Sox3 reversed these phenotypes.
|
28618953 |
2017 |
Malignant neoplasm of breast
|
0.020 |
Biomarker
|
disease |
BEFREE |
The B-CAN platform runs on Apache server and interacts with the backstage of MySQL database by PHP.
|
29312567 |
2017 |
Osteosarcoma
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
The effects of SOX3 expression on OS cell biological traits were investigated by overexpressing and downregulating SOX3 protein.
|
28335789 |
2017 |
Squamous cell carcinoma of esophagus
|
0.020 |
Biomarker
|
disease |
BEFREE |
Thus, Sox-3 may become a new prognostic marker and therapeutic target in ESCC.
|
28670361 |
2017 |
Neurodegenerative Disorders
|
0.020 |
Biomarker
|
group |
BEFREE |
Altogether, the AAV-PHP.B viral platform enables non-invasive, widespread, and long-lasting global neural expression of therapeutic genes, such as GBA1, providing an invaluable approach to treat neurodegenerative diseases with diffuse brain pathology such as synucleinopathies.
|
28882452 |
2017 |
Osteosarcoma of bone
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
The effects of SOX3 expression on OS cell biological traits were investigated by overexpressing and downregulating SOX3 protein.
|
28335789 |
2017 |
Breast Carcinoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
The B-CAN platform runs on Apache server and interacts with the backstage of MySQL database by PHP.
|
29312567 |
2017 |
Childhood Osteosarcoma
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
The effects of SOX3 expression on OS cell biological traits were investigated by overexpressing and downregulating SOX3 protein.
|
28335789 |
2017 |
Malignant neoplasm of endometrium
|
0.010 |
Biomarker
|
disease |
BEFREE |
Silencing of Sox3 in endometrial cancer stem cell upregulated the epithelial marker E-cadherin, downregulated the mesenchymal marker vimentin, and significantly reduced cell invasion in vitro; overexpression of Sox3 reversed these phenotypes.
|
28618953 |
2017 |